In March, a joint statement by the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions (SCAI) upheld primary PCI as the gold standard but said fibrinolytics could be considered. A second statement from SCAI took a similar stance favoring primary PCI and acknowledging that fibrinolysis could play a role in low-risk patients, especially at hospitals where a high COVID-19 burden is straining staff and resources.
|